Cadaver versus living donor kidneys: Impact of donor factors on antigen induction before transplantation

Kidney International

Volumn 56, Issue 4, 1999, Pages 1551-1559

  Koo, Dicken D H ^a   Welsh, Kenneth I ^a   McLaren, Andrew J ^a   Roake, Justin A ^a   Morris, Peter J ^a   Fuggle, Susan V ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adhesion molecules; Allografts; Cadaver organ donors; Rejection; Renal transplantation

Indexed keywords

ANTIGEN; DESMOPRESSIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; CADAVER KIDNEY; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 0032861110     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00657.x     Document Type: Conference Paper

References (50)

1. CECKA JM: Outcome statistics of renal transplants with an emphasis on long-term survival. Clin Transplant 8:324-327, 1994
2. th ed), edited by MORRIS PJ, Philadelphia, Saunders, 1994, pp 504-523
3. JONES JW JR, GILLINGHAM KJ, SUTHERLAND DE, PAYNE WD, DUNN DL, GORES PF, GRUFSSNER RW, NAJARIAN JS, MATAS AJ: Successful long-term outcome with 0-haplotype-matched living-related kidney donors. Transplantation 57:512-515, 1994
4. TERASAKI PI, CECKA JM, GJERTSON DW, TAKEMOTO S: High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 333:333-336, 1995
5. CECKA JM: In sickness and in health: High success rates of kidney transplants between spouses. Transplant Rev 10:216-224, 1996
6. LOWELL JA, BRENNAN DC, SHENOY S, HAGERTY D, MILLER S, CERIOTH C, COLE B, HWOARD TK: Living-unrelated renal transplantation provides comparable results to living-related renal transplantation: A 12-year single-center experience. Surgery 119:538-543, 1996
7. THIFL G: Living unrelated kidney transplantation, in procurement Preservation and Allocation of Vascularized Organs, edited by COLLINS GM, DUBERNARD JM, LAND W, PERSIJN GG, Dordrecht, Kluwer Academic, 1997, pp 367-373
8. SUZUKI MM, CECKA JM, TERASAKI PI: Unrelated living donor kidney transplants. Br Med Bull 53:854-859, 1997
9. OPELZ G: Impact of HLA compatibility on survival of kidney transplants from unrelated live donors. Transplantation 64:1473-1475, 1997
10. KOO DDH, WELSH KI, ROAKE JA, MORRIS PJ, FUGGLE SV: Ischemia/reperfusion injury in human kidney transplantation: An immunohistochemical analysis of changes after reperfusion. Am J Pathol 153:557-566, 1998
11. FUGGLE SV, KOO DDH: Cell adhesion molecules in clinical renal transplantation. Transplantation 65:763-769, 1998
12. FUGGLE SV, McWHINNIE DL, CHAPMAN JR, TAYLOR HM, MORRIS PJ: Sequential analysis of HLA-class II antigen expression in human renal allografts. Induction of tubular class II antigens and correlation with clinical parameters. Transplantation 42:144-150, 1986
13. FUGGLE SV, McWHINNIE DL, MORRIS PJ: Precise specificity of induced tabular HLA-class II antigens in renal allografts. Transplantation 44:214-220, 1987
14. BISHOP GA, HALL BM: Expression of leukocyte and lymphocyte adhesion molecules in the human kidney. Kidney Int 36:1078-1085, 1989
15. RAFTERY MJ, SERON D, KOFFMAN G, HARILAY B, JANOSSY G, CAMERON JS: The relevance of induced class II HLA antigens and macrophage infiltration in early renal allograft biopsics. Transplantation 48:238-243, 1989
16. SERON D, CAMERON JS, HASKARD DO: Expression of VCAM-I in the normal and diseased kidney. Nephrol Dial Transplant 6:917-922, 1991
17. FUGGLE SV, SANDERSON JB, GRAY DW, RICHARDSON A, MORRIS PJ: Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys-correlation with intragraft events. Transplantation 55:117-123, 1993
18. HILL PA, MAIN IW, ATKINS RC: ICAM-1 and VCAM-1 in human renal allograft rejection. Kidney Int 47:1383-1391, 1995
19. JONES RM, MURIE JA, ALLEN RD, TING A, MORRIS PJ: Triple therapy in cadaver renal transplantation. Br J Surg 75:4-8, 1988
20. DALCHAU R, KIRKLEY J, FABRE JW: Monoclonal antibody to a human leukocyte-specific membrane glycoprotein probably homologous to the leukocyte-common (L-C) antigen of the rat. Eur J Immunol 10:737-744, 1980
21. BEVERLEY PC, CALLARD RE: Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody. Eur J Immunol 11:329-334, 1981
22. HOGG N, MACDONALD S, SLUSARENKO M, BEVERLEY PC: Monoclonal antibodies specific for human monocytes, granulocytes and endothelium. Immunology 53:753-767, 1984
23. KELLY PM, BLISS L, MORTON JA, BURNS J, McGEE JO: Monoclonal antibody EBM/II: High cellular specificity for human macrophages. J Clin Pathol 41:510-515, 1988
24. McEVER RP, MARTIN MN: A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 259:9799-9804, 1984
25. BEVILACQUA MP, POBAR JS, MENDRICK DL, COTRAN RS, GIMBRONE MA JR: Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 84:9238-9242, 1987
26. LAWRENCE MB, SPRINGER TA: Neutrophils roll on E-selectin. J Immunol 151:6338-6346, 1993
27. ABBASSI O, KISHIMOTO TK, McINTYRE LV, ANDERSON DC, SMITH CW: E-selectin supports neutrophil rolling in vitro under conditions of flow. J Clin Invest 92:2719-2730, 1993
28. AUSTRUP F, VESTWEBER D, BORGES E, LOHNING M, BRAUER R, HERZ U, RENZ H, HALLMANN R, SCHEFFOLDS A, RADBRUCH A, HAMANN A: P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 385:81-83, 1997
29. BROCKMEYER C, ULBRECHT M, SCHENDEL DJ, WEISS EH, HILLEBRAND G, BURKHARDI K, LAND W, GOKEL MJ, RIETHMULLER G, FEUCHT HE: Distribution of cell adhesion molecules (ICAM-I, VCAM-I, ELAM-1) in renal tissue during allograft rejection. Transplantation 55:610-615, 1993
30. MORGAN JD, LYCETI A, HORSBURGH T, NICHOLSON ML, VEITCH PS, BELL PR: The importance of E-selectin as a marker for renal transplant rejection. Transplant Immunol 2:326-330, 1994
31. FAULL RJ, RUSS GR: Tubular expression of intercellular adhesion molecule-1 during renal allograft rejection. Transplantation 48:226-230, 1989
32. LIN Y, KIRBY JA, CLARK K, SHENTON BK, FORSYIHF JLR, PROUD G, TAYLOR RMR: Renal allograft rejection: Induction and function of adhesion molecules on cultured epithelial cells. Clin Exp Immunol 90:111-116, 1992
33. LIN Y, KIRBY JA, BROWELL DA, MORLEY AR, SHENTON BK, PROUD G, TAYLOR RMR: Renal allograft rejection: Expression and function of VCAM-1 on tubular epithelial cells. Clin Exp Immunol 92:145-151, 1993
34. SPRINGER TA: Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57:827-872, 1995
35. KIRBY JA, RAJASEKAR MR, LIN Y, PROUD G, TAYLOR RMR: Interaction between T lymphocytes and kidney epithelial cells during renal allograft rejection. kidney Int 43(Suppl 39):S124-S128, 1993
36. GRUNDMANN R, KAMMERER B, FRANKE E, PICHI MAIER H: Effect of hypotension on the results of kidney storage and the use of dopamine under these conditions. Transplantation 32:184-187, 1981
37. HERUGERS P, LEUNENS V, TJANDRA-MAGA TB, MUBAGWA K, FLAMENG W: Changes in organ perfusion after brain death in the rat and its relation to circulating catecholamines. Transplantation 62:330-335, 1996
38. LANGERON O, COUTURE P, MATEO J, RIOU B, PANSARD J-L, CORIAT P: Oxygen consumption and delivery relationship in brain-dead organ donors. Br J Anaesth 76:783-789, 1996
39. MERTES PM, EL ABASSI K, JABOIN Y, BURTIN P, PINELLI G, CARTEAUX JP, BURLET C, BOULANGE M, VILLEMOT JP: Changes in hemodynamic and metabolic parameters following induced brain death in the pig. Transplantation 58:414-418, 1994
40. PELOSI G, ZANGHI F, AGNES S, MAGALINI SC: Maintenance of unstable kidney donors. Eur J Anaesthesiol 3:209-217, 1986
41. HIRSCHL MM, MATZNER MP, HUBER WO, BINDER M, ROGGLA G, DERFLER K, MUHLBACHER F, LAGGNER AN: Effect of desmopressin substitution during organ procurement on early renal allograft function. Nephrol Dial Transplant 11:173-176, 1996
42. GUESDE R, BENOTT B, LEBLANC I, OURAHMA S, GOARIN J-P, CORIAT P, RIOU B: Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Lancet 352: 1178-1181, 1998
43. MANUCCI PM: Desmopressin: A nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 72: 1449-1455, 1988
44. MANUCCI PM: Desmopressin: A nontransfusional hemostatic agent. Annu Rev Med 41:55-64, 1990
45. KANWAR S, WOODMAN RC, POON MC, MUROHARA T, LEFER AM, DAVENPECK KL, KUBES P: Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules. Blood 86:2760-2766, 1995
46. WUN T, PAGLIERONI TG, LACHANT NA: Desmopressin stimulates the expression of P-selectin on human platelets in vitro. J Lab Clin Med 125:401-409, 1995
47. HASHEMI S, PALMER DS, AYE MT, GANZ PR: Platelet-activating factor secreted by DDAVP-treated monocytes mediates von Wille-brand factor release from endothelial cells. J Cell Physiol 154:496-505, 1993
48. PRATSCHKE J, WILHELM MJ, KUSAKA M, BASKER M, COOPER DKC, HANCOCK WW, TILNEY NL: Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 67:343-348, 1999
49. TAKADA M, NADEAU KC, HANCOCK WW, MACKENZIE HS, SHAW GD, WAAGA AM, CHANDRAKER A, SAYEGH MH, TILNEY NL: Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 65:1533-1542, 1998
50. AMADO JA, LOPEZ-ESPADAS F, VAZQUEZ-BARQUERO A, SALAS E, RIANCHO JA, LOPEZ-CORDOVILLA JJ, GARCIA-UNZUETA MT: Blood levels of cytokines in brain-dead patients: Relationship with circulating hormones and acute-phase reactants. Metabolism 44:812-816, 1995